Esperion $Esperion Therapeutics (ESPR.US)$ We reiterate Strong Buy rating. Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 million Americans take statin drugs, we see continued prescription growth & expect over 5...
+20
13
PLUG Lowered To HOLD, Losses Still Predicted In 2025. ESPR Reiterated Strong Buy, Profitable In 2025
$Plug Power (PLUG.US)$We lowered our rating to HOLD based on earnings growth is still not enough to gain profits. We believe Trump will win the 2024 election, and that will put pressure on Plug Power. End of 2025 PLUG is estimated to have a loss of ($-0.57) a share. We expect more dilution will also be needed.
Esperion $Esperion Therapeutics (ESPR.US)$ We reiterate Strong Buy rating. Esperion has...
Esperion $Esperion Therapeutics (ESPR.US)$ We reiterate Strong Buy rating. Esperion has...
1
1
$Esperion Therapeutics (ESPR.US)$ Esperion Therapeutics Non Statin Multi-Billion future Drug NEXLIZET has Reversed Type2 Diabetes After Removing Statin Drug to Lower Bad Cholesterol
$Esperion Therapeutics (ESPR.US)$
https://www.youtube.com/watch?v=DMW-BtT7WWE
From YouTube
Latest is Esperion has moved it's earnings date forward from scheduled 11/11 to 11/05. We know speculation is that Esperion might be selling some or all of the rights to it's Cholesterol d...
$Esperion Therapeutics (ESPR.US)$
https://www.youtube.com/watch?v=DMW-BtT7WWE
From YouTube
Latest is Esperion has moved it's earnings date forward from scheduled 11/11 to 11/05. We know speculation is that Esperion might be selling some or all of the rights to it's Cholesterol d...
+16
12
1
$Esperion Therapeutics (ESPR.US)$
BELOW are a lots of collected research facts from some of my previous articles on ESPR, this is NOT a pump article, this is real research for serious investors that are looking for an investment of a lifetime. Please review it and do your own research. I personally continue to buy ESPR stock every week in my investm...
BELOW are a lots of collected research facts from some of my previous articles on ESPR, this is NOT a pump article, this is real research for serious investors that are looking for an investment of a lifetime. Please review it and do your own research. I personally continue to buy ESPR stock every week in my investm...
From YouTube
17
5
1
#1 Stock To Invest in for 10X+Upside Is ESPR. $AMD From $3 To $100+ Now This Investor BETS $22M In ESPR, Predicts this $2 stock will be $30 to $50 in 3 years If not bought out soon.
Exciting NEWS Today Oct 11th, MILOS study highlights potential of bempedoic acid to advance dyslipidemia treatment: GlobalData
Daiichi Sankyo has recently announced the final two-year follow-up data from the German cohort ...
Exciting NEWS Today Oct 11th, MILOS study highlights potential of bempedoic acid to advance dyslipidemia treatment: GlobalData
Daiichi Sankyo has recently announced the final two-year follow-up data from the German cohort ...
+14
22
1
$Esperion Therapeutics (ESPR.US)$ Esperion is our favorite investment for a 10x return. We believe ESPR should be valued much higher considering all these facts shown below:
Esperion Therapeutics Selling The Only Statin Alternative Oral Pill Is Expected To Generate Billions. This Takeover Candidate Should Be In Your P...
Esperion Therapeutics Selling The Only Statin Alternative Oral Pill Is Expected To Generate Billions. This Takeover Candidate Should Be In Your P...
+13
19
1
An Investment Now In This Company Should Return 10 X Your Money.
$Esperion Therapeutics (ESPR.US)$Is going to be one of those stocks people wish they loaded up on, but I highly Suggest you buy some now. This isn't a Pump article. Read the facts & decide for yourself. People mostly miss out the the explosive growth curve and ...
$Esperion Therapeutics (ESPR.US)$Is going to be one of those stocks people wish they loaded up on, but I highly Suggest you buy some now. This isn't a Pump article. Read the facts & decide for yourself. People mostly miss out the the explosive growth curve and ...
+15
17
Plug to deliver two 30-tons-per-day hydrogen liquefaction systems to TC Energy
LATHAM, N.Y., January 10, 2023 — Plug Power Inc. (NASDAQ: PLUG), a leading provider of turnkey hydrogen solutions for the global green hydrogen economy, has been awarded an order to deliver two 30-tons-per-day (TPD) hydrogen liquefaction systems (also known as hydrogen liquefiers) to TC Energy Corporation (TSX, NYSE: TRP). These 30TPD hydrogen liquefaction syst...
LATHAM, N.Y., January 10, 2023 — Plug Power Inc. (NASDAQ: PLUG), a leading provider of turnkey hydrogen solutions for the global green hydrogen economy, has been awarded an order to deliver two 30-tons-per-day (TPD) hydrogen liquefaction systems (also known as hydrogen liquefiers) to TC Energy Corporation (TSX, NYSE: TRP). These 30TPD hydrogen liquefaction syst...
13
10
Expect PLUG Power Short Squeeze 293 Million Shares Short. Plug has A.i Energy Advantage
PLUG Power Stock Could Soon Double SHORT Squeeze To $4. A.i Power Based Investment
$Plug Power (PLUG.US)$ PLUG beaten down by short sellers while the company has now set itself up to start generating substantial retur...
PLUG Power Stock Could Soon Double SHORT Squeeze To $4. A.i Power Based Investment
$Plug Power (PLUG.US)$ PLUG beaten down by short sellers while the company has now set itself up to start generating substantial retur...
4
2
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)